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This Month in the Journal
Spastin-Gene Mutations, by Svenson et al. (p. 1077)
Autosomal dominant pure hereditary spastic paraplegia
(SPG), a neurodegenerative disorder characterized by
gait difficulties, leg weakness and spasticity, and hyper-
reflexia, is most often caused by mutations in SPG4, the
gene encoding spastin. This protein is a member of the
AAA family of ATPases, which are thought to act as
molecular chaperones in a variety of cellular processes.
Almost all of the mutations that have been identified in
the spastin gene affect, either directly or indirectly, the
spastin AAA motif, which serves as the active domain
for the protein. In this study by Svenson et al., 15 families
with autosomal dominant pure SPG were screened for
mutations in SPG4. Mutations were identified in 11 of
the families, and all of these mutations are predicted to
affect the AAA motif. One splice-site mutation in this
cohort, IVS94arg, results in the deletion of exon 9
from some of the encoded transcripts. However, normal,
full-length transcript is also produced from the mutant
allele. Attempts to recreate the leaky expression of this
mutation in a minigene construct were not successful
until flanking exon and intron sequences were included
in the construct. The authors propose two main impli-
cations of these results: first, difficulty in the reconstruc-
tion of leaky expression of the splice-site mutation in
vitro suggests that splicing experiments using minigene
constructs should be interpreted with caution; second,
although a model of haploinsufficiency for autosomal
dominant SPG can be invoked, the production of some
normal transcript from the IVS94arg mutation in an
affected individual suggests that smaller (!50%) reduc-
tions in spastin can also cause disease. Thus, the vari-
ability of expression of some SPG4 mutations may ex-
plain the variability in symptom severity and progression
that is seen with SPG.
Transaldolase Deficiency, by Verhoeven et al.
(p. 1086)
Verhoeven et al. describe a relatively new category of in-
born errors of metabolism, errors in polyol metabolism.
They present a girl with mild bleeding problems, an en-
larged clitoris, aortic coarctation, and liver cirrhosis. She
had elevated concentrations of polyols—including ara-
bitol, ribitol, and erythritol—in her urine. In a trans-
aldolase-activity assay, cultured lymphoblasts and eryth-
rocytes from the patient exhibited a buildup of the sub-
strate and a lack of the product of the transaldolase
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reaction, indicating a transaldolase deficiency. Sequenc-
ing of the TALDO1 gene for transaldolase revealed a
homozygous deletion of 3 bp in the patient, which results
in the loss of serine 171 in the protein. Transaldolase,
along with transketolase, links the pentose phosphate
pathway with glycolysis. The authors propose that the
transaldolase deficiency leads to polyol accumulation
following the inadequate conversion of sugar phosphate
intermediates in this metabolic pathway.
Origin of MECP2 Mutations in RTT, by Trappe et al.
(p. 1093)
The scarcity of males with Rett syndrome (RTT) has led
many people to propose that it is an embryonic lethal
disease in males. Carriers of mutations in MECP2, the
gene for RTT, are affected and are unlikely to reproduce
and passMECP2mutations to children. Therefore, RTT
is almost always a result of de novo mutations. This led
George Thomas to propose that a high male:female
germline mutation rate could explain the difference in
the number of males and females affected by RTT (see
Trappe et al.’s citation of Thomas [1996]). Because
MECP2 is on the X chromosome, fathers cannot pass
MECP2 mutations to their sons. If more de novo mu-
tations arise in males, and if they can pass these mu-
tations only to their daughters, then most affected in-
dividuals will be girls. Subsequently, most of the affected
girls will inherit a MECP2 mutation from their fathers,
rather than from their mothers. Trappe et al. test this
hypothesis through an examination of the parent of or-
igin of theMECP2mutations in 27 females affectedwith
RTT. Through use of polymorphisms in MECP2, they
were able to determine which parent passed the mutated
copy of MECP2 to each affected girl. In 26 of 27 cases,
the mutation came from the father. These data provide
a likely explanation for the high female:male sex ratio
in RTT, and they suggest that, in fact, RTT may not be
male lethal.
WNT-4 and Dosage-Sensitive Sex Reversal, by Jordan
et al. (p. 1102)
Wnt-4 is known to be involved in sex determination in
mice. Deletion of this gene leads to masculinization of
XX mice. This observation, along with the persistence
of Wnt-4 expression in the developing ovary but not in
the developing male gonad, suggests that Wnt-4 plays
an important role in ovarian development. To determine
whether human WNT4 also plays a role in sex deter-
mination, Jordan et al. first cloned the human homolog
Am. J. Hum. Genet. 68:i–ii, 2001
ii
of Wnt-4 and localized it to chromosome 1p35. An
XY–sex-reversed patient was identified who carried a
duplication of the chromosome 1p31-p35 region, and
this duplication includedWNT4. WNT4 is expressed in
fibroblasts from the sex-reversed patient but not in those
from normal males, suggesting that WNT-4 may have
played a role in the sex reversal. To determine the con-
sequences of WNT-4 overexpression, the authors trans-
fectedWnt-4 cDNA into mouse Leydig and Sertoli cells.
WNT-4 overexpression results in strong up-regulation
of Dax1, a transcription factor known to play a role in
sex determination. BecauseDax1 andWnt-4 also exhibit
similar expression patterns in embryos and can, when
they are in excess, feminize XY mouse embryos, both
genes may play a role in the same dosage-sensitive sex-
determination pathway.
Disruption of the Imprinting Center, by Buiting et al.
(p. 1290)
Imprinting defects at chromosome 15q11-q13 can lead
to either Prader-Willi syndrome (PWS) or Angelman syn-
drome (AS), depending on the exact sequences involved.
An imprinting center has been localized to the SNURF-
SNRPN locus in this region. The shortest region of de-
letion overlap for each disease has been used to define
two critical regions within this locus: the AS-SRO (AS
shortest region of overlap) is 35 kb upstream of exon 1
of SNRPN, and the PWS-SRO (PWS shortest region of
overlap) includes exon 1. Deletions in PWS-SRO are
important for the establishment or maintenance of the
paternal imprint. The AS-SRO and PWS-SRO regions
are believed to interact to establish the maternal imprint
in this region, although a demonstration of this inter-
action has not been made in humans. Buiting et al. iden-
tified two siblings who are affected by AS and who have
a rearrangement in the imprinting center of chromosome
15q. The rearrangement is a 1–1.5-Mb inversion that
disrupts the imprinting center, moving the AS-SRO away
from the PWS-SRO and putting it in an inverted ori-
entation. The mother and the maternal grandfather also
carry the inversion, although neither is affected. These
results suggest that transmission of the inversion through
the maternal, but not the paternal, germline leads to AS.
Because the mother shows normal methylation and ex-
pression of the MKRN3 gene in this region, the region
can be paternally imprinted, regardless of the inversion.
The association between maternal transmission of the
imprinting-center inversion and Angelman syndrome
suggests that, to establish thematernal imprint, the PWS-
SRO and AS-SRO need to be in close proximity or in a
particular orientation.
Congenital Blindness and RPGRIP1, by Dryja et al.
(p. 1295)
Many cases of X-linked retinitis pigmentosa are caused
bymutations inRPGR.Dryja et al. decided to seewhether
mutations in the gene for the recently identified
RGPR-interacting protein, RPGRIP1, are also associated
with retinal degeneration. After the complete human
RPGRIP1 sequence was determined, on the basis of ho-
mology with the murine sequence, patients with Leber
congenital amaurosis, an autosomal recessive retinal
dystrophy, were screened for mutations in this gene. Of
the 57 patients, 3 had mutations that created premature
stop codons in RPGRIP1. Three rare missense variants
were also discovered in other patients, but their path-
ogenicity was not clear. Although the number of
RPGRIP1 mutations is small, the discovery of four null
mutations in three patients with Leber congenital am-
aurosis suggests that the mutations are responsible for
their retinal disease.
KATHRYN BEAUREGARD
Deputy Editor
